Search

for
Search:

Sort by

Research

990-1000 / 1000+ results

Hydroxychloroquine Modulates the Progression of Experimentally Induced Benign Prostatic Hyperplasia in Rats via Targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL Pathways: Computational and In Vivo Studies

research Hydroxychloroquine modulates the progression of experimentally induced benign prostatic hyperplasia in rats via targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL pathways: computational and in vivo studies

1 citations , June 2025 in “Scientific Reports”

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

research Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in patients with breast cancer.

June 2023 in “Journal of Clinical Oncology”

CDK4/6 inhibitors may cause hair loss in breast cancer patients.

research The Benefits of Dual Inhibition of 5α Reductase

4 citations , September 2006 in “European Urology Supplements”

Dutasteride reduces DHT and improves BPH symptoms more effectively than finasteride.

research Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document

36 citations , June 2017 in “Journal of Cutaneous Medicine and Surgery”

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

Efficacy and Safety of Baricitinib in Adult Patients With Severe Alopecia Areata With or Without an Atopic Background From Two Randomized, Placebo-Controlled, Phase 3 Trials

research 34007 Efficacy and safety of baricitinib in adult patients with severe alopecia areata with or without an atopic background from 2 randomized, placebo-controlled, phase 3 trials

3 citations , September 2022 in “Journal of the American Academy of Dermatology”

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

research Janus kinase inhibitors in dermatology: A systematic review

116 citations , February 2017 in “Journal of the American Academy of Dermatology”

JAK inhibitors help with skin conditions but need more research on dosing and safety.

research A new era for alopecia areata: New treatments and improved knowledge of the condition

1 citations , February 2024 in “JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology”

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

research Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review

8 citations , July 2024 in “Children”

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

research 5‐alpha‐reductase inhibitor treatment for frontal fibrosing alopecia: an evidence‐based treatment update

21 citations , March 2018 in “JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology”

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

research This Month in JAAD: October 2021

August 2021 in “Journal of the American Academy of Dermatology”

Oral baricitinib is effective and safe for treating alopecia areata.

← Previous page